Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00124007
What this trial is testing

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Testing effectiveness (Phase 2)Study completedNCT06017609
What this trial is testing

Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

Who this might be right for
Chronic Heart Failure
Akros Pharma Inc. 314
Testing effectiveness (Phase 2)Study completedNCT00430898
What this trial is testing

Basiliximab in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Cerimon Pharmaceuticals 181
Large-scale testing (Phase 3)Study completedNCT05140863
What this trial is testing

To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia

Who this might be right for
Postherpetic Neuralgia
Haisco Pharmaceutical Group Co., Ltd. 372
Testing effectiveness (Phase 2)Study completedNCT01742052
What this trial is testing

Dose-finding Study of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 415
Large-scale testing (Phase 3)Study completedNCT01979952
What this trial is testing

Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 113
Testing effectiveness (Phase 2)Study completedNCT03108534
What this trial is testing

Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 65
Large-scale testing (Phase 3)Study completedNCT00134199
What this trial is testing

6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Who this might be right for
Obesity
Pfizer 282
Early research (Phase 1)Study completedNCT02017899
What this trial is testing

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Who this might be right for
Shigellosis
GSK Vaccines Institute For Global Health S.r.l. 50
Early research (Phase 1)Study completedNCT04168333
What this trial is testing

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B Virus (HBV)
Tasly Tianjin Biopharmaceutical Co., Ltd. 36
Large-scale testing (Phase 3)Ended earlyNCT04619433
What this trial is testing

Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 48
Large-scale testing (Phase 3)Study completedNCT04716933
What this trial is testing

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 201
Early research (Phase 1)Study completedNCT02572349
What this trial is testing

Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

Who this might be right for
Healthy
Cyclerion Therapeutics 24
Large-scale testing (Phase 3)WithdrawnNCT05061771
What this trial is testing

Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)

Who this might be right for
Bullous Pemphigoid
AKARI Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00760864
What this trial is testing

Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Takeda 432
Testing effectiveness (Phase 2)Study completedNCT02704364
What this trial is testing

NGM282 in Patients With Primary Sclerosing Cholangitis

Who this might be right for
Primary Sclerosing Cholangitis
NGM Biopharmaceuticals, Inc 62
Testing effectiveness (Phase 2)Study completedNCT03106532
What this trial is testing

Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

Who this might be right for
Normal Tension Glaucoma
pH Pharma 119
Testing effectiveness (Phase 2)Study completedNCT06081621
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Regend Therapeutics 23
Large-scale testing (Phase 3)Study completedNCT02630316
What this trial is testing

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseCombined Pulmonary Fibrosis and Emphysema
United Therapeutics 326
Testing effectiveness (Phase 2)Study completedNCT02951429
What this trial is testing

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 177
Next Page